Mark Rosenthal, DO
Family Medicine · Homestead, FLNPI 1659470201
Payments from drug & device makers
Across 5,273 payments — averaging $2006.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$4.3M
- Bavarian Nordic A/s$1.9M
- Astrazeneca UK Limited$1.4M
- Pfizer$1.1M
- Regeneron$761K
- Johnson & Johnson$483K
- plus $693K from 9 others
Across 23 payments — averaging $369.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$6K
- GSK$3K
- Eli Lilly$320
What the payments were for
- Travel & lodging$2,37173%
- Food & beverage$88627%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 4,457 | $4,297,037 |
| Bavarian Nordic A/s | 261 | $1,927,152 |
| Astrazeneca UK Limited | 4 | $1,356,199 |
| Pfizer | 80 | $1,063,666 |
| Regeneron | 280 | $760,773 |
| Johnson & Johnson | 38 | $482,526 |
| Eli Lilly | 4 | $393,643 |
| GSK | 27 | $134,885 |
| Mylan Specialty L.p. | 17 | $85,917 |
| Alnylam Pharmaceuticals Inc. | 94 | $43,040 |
| Chiesi USA, Inc. | 5 | $15,837 |
| Merck | 1 | $10,332 |
| Novartis | 3 | $9,450 |
| Impulse Dynamics (USA) Inc. | 1 | $128 |
| Fisher & Paykel Healthcare Inc | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,580,633 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Homestead
- Adolfo CueliHomestead$7.9M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.